By Nyasha Kunyiswa AUTHORITIES are pushing for pharmaceutical companies to expedite retooling their industrial technology and be able to manufacture anti-retroviral (ARV) drugs locally. This comes as Zimbabwe is currently importing its ARVs from India and China. Speaking at a policy and regulatory review meeting aimed at resolving bottlenecks in the Sadc region ARV value…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions